PDF) Statins, Fibrates and Myopathy: Pathophysiological Mechanism, Risk Factors and Laboratory Markers

Statins, Fibrates and Myopathy: Pathophysiological Mechanism, Risk Factors and Laboratory Markers

Statin Toxicity Circulation Research

bok%3A978-1-4939-0515-7.pdf ?auth66=1397940469_51b8ba57efa3ddcad3f8aa303951bc25&ext=

Lipid-Modulating Agents for Prevention or Treatment of COVID-19 in Randomized Trials

Effects of statins on myocarditis: A review of underlying molecular mechanisms - ScienceDirect

Pharmacological Actions of Statins: A Critical Appraisal in the Management of Cancer

Vitamins

Novel potassium binders: a clinical update

triglyc-drugs-Image001.jpg

Muscle- and skeletal-related side-effects of statins: tip of the iceberg? - Johann Auer, Helmut Sinzinger, Barry Franklin, Robert Berent, 2016

Phenotype Standardization for Statin‐Induced Myotoxicity - Alfirevic - 2014 - Clinical Pharmacology & Therapeutics - Wiley Online Library

Regulatory Effects and Molecular Mechanisms of Tea and Its Active Compounds on Nonalcoholic Fatty Liver Disease